Skip to main content

Find Clinical Trials

Home
Conditions
Blood-Borne Infections

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,262 public trials 443 recruiting studies

Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Gut Microbiota, PGx and INSTIs Response

NCT04805944

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Cliniques universitaires Saint-Luc Brussels, Belgium

View Trial Details

Completed

Impact of COVID-19 on Provision and Uptake of Prevention of Mother-to-child Transmission of HIV Services in Zimbabwe

NCT04782739

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +27 more
Locations: Kuwadzana Polyclinic Harare, Zimbabwe

Mabvuku Polyclinic Harare, Zimbabwe

View Trial Details

Completed

Exploring Racial Disparities in Sleep Health and Neurocognitive Function

NCT04015830

Conditions: AIDS Dementia Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +21 more
Locations: University of Alabama Tuscaloosa, Alabama, United States

View Trial Details

Completed

Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment

NCT06403787

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: University Center for Health Sciences Guadalajara, Jalisco, Mexico

View Trial Details

Completed

A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women

NCT05746065

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: ICAP, eSwatini Prevention Center Mbabane, Hhohho Region, Eswatini

Kenya Medical Research Institute (KEMRI) Nairobi, Kenya

Queen Elizabeth Central Hospital Blantyre, Malawi

Perinatal HIV Research Unit (PHRU) Johannesburg, Gauteng, South Africa

View all 20 locations

View Trial Details

Completed

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

NCT02616874

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Germans Trias i Pujol Hospital Badalona, Barcelona, Spain

Clinic Hospital Barcelona, Spain

View Trial Details

Completed

SSRI Effects on Depression and Immunity in HIV/AIDS

NCT02620150

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Behavior, +18 more
Locations: University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals

NCT05208125

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Germans Trias i Pujol Hospital Badalona, Barcelona, Spain

View Trial Details

Completed

Evaluation of the Trans Women Connected Mobile App for Changes in Sexual Health-related Behavior Among Transgender Women

NCT03897049

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +20 more
Locations: ETR Scotts Valley, California, United States

View Trial Details

Completed

Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)

NCT04676724

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Sacramento, California, United States

GSK Investigational Site Iowa City, Iowa, United States

GSK Investigational Site Detroit, Michigan, United States

GSK Investigational Site New York, United States

View all 49 locations

View Trial Details